Long-chain acylcarnitines (LCACs) increase rapidly within minutes after the onset of ischemia in vivo or hypoxia in vitro and produce a time-dependent reversible reduction in gap junctional conductance in isolated myocyte pairs. The present study was performed to assess whether LCACs contribute to cellular uncoupling in response to ischemia in isolated bloodperfused rabbit papillary muscles by use of simultaneous measurements of transmembrane action potentials, extracellular electrograms, extracellular K', and tissue LCACs and ATP. LCACs increased threefold in response to 20 minutes of no-flow ischemia from 127±5 to 397±113 pmol/mg protein (P<.01), concomitant with the onset of cellular uncoupling, extracellular K' accumulation, and a marked reduction in conduction velocity and action potential duration. To assess whether inhibition of the accumulation of LCACs modified the electrophysiological alterations during ischemia, muscles were pretreated with either sodium 2-(5-(4-chlorophenyl)-pentyl)oxirane-2-carboxylate (POCA, 10 gmol/L) or oxfenicine (100 ,umol/L), inhibitors of carnitine acyltransferase I. Both POCA S udden cardiac death in the setting of acute myocardial ischemia usually results from spontaneous ventricular tachycardia degenerating into ventricular fibrillation.1,2 Spontaneous malignant arrhythmias occur within minutes of the onset of ischemia in vivo and are primarily due to conduction delay and block leading to intramural reentry.3,4 Changes in membrane excitability and cell-to-cell uncoupling are likely to represent the basic electrophysiological alterations leading to disturbances in propagation. As shown previously, a decrease in excitability occurs immediately after coronary occlusion,5 whereas the onset of electrical cell-to-cell uncoupling occurs with a delay of 10 to 15 minutes.6 At present, the metabolic events that initiate cellular uncoupling are unknown. The blood-perfused papillary muscle preparation is an attractive system in which to evaluate precisely how discrete biochemical events contribute to the electrophysiological derangements induced by myocardial ischemia.
Long-chain acylcarnitines (LCACs) increase rapidly within minutes after the onset of ischemia in vivo or hypoxia in vitro and produce a time-dependent reversible reduction in gap junctional conductance in isolated myocyte pairs. The present study was performed to assess whether LCACs contribute to cellular uncoupling in response to ischemia in isolated bloodperfused rabbit papillary muscles by use of simultaneous measurements of transmembrane action potentials, extracellular electrograms, extracellular K', and tissue LCACs and ATP. LCACs increased threefold in response to 20 minutes of no-flow ischemia from 127±5 to 397±113 pmol/mg protein (P<.01), concomitant with the onset of cellular uncoupling, extracellular K' accumulation, and a marked reduction in conduction velocity and action potential duration. To assess whether inhibition of the accumulation of LCACs modified the electrophysiological alterations during ischemia, muscles were pretreated with either sodium 2-(5-(4-chlorophenyl)-pentyl)oxirane-2-carboxylate (POCA, 10 gmol/L) or oxfenicine (100 ,umol/L), inhibitors of carnitine acyltransferase I. Both POCA S udden cardiac death in the setting of acute myocardial ischemia usually results from spontaneous ventricular tachycardia degenerating into ventricular fibrillation.1,2 Spontaneous malignant arrhythmias occur within minutes of the onset of ischemia in vivo and are primarily due to conduction delay and block leading to intramural reentry. 3, 4 Changes in membrane excitability and cell-to-cell uncoupling are likely to represent the basic electrophysiological alterations leading to disturbances in propagation. As shown previously, a decrease in excitability occurs immediately after coronary occlusion,5 whereas the onset of electrical cell-to-cell uncoupling occurs with a delay of 10 to 15 minutes. 6 At present, the metabolic events that initiate cellular uncoupling are unknown. The blood-perfused papillary muscle preparation is an attractive system in which to evaluate precisely how discrete biochemical events contribute to the electrophysiological derangements induced by myocardial ischemia.
Several lines of evidence from our laboratory and others over the last several years indicate that a major and oxfenicine completely prevented the increase in LCACs even with 40 minutes of ischemia (138±37 and 56±4 pmol/mg protein, respectively), associated with a marked delay in the onset and progression of cellular uncoupling and ischemic contracture. Although POCA and oxfenicine did not affect either the initial early rise in extracellular K' or the initial fall in conduction velocity, both agents markedly delayed the secondary rise in extracellular K' as well as the secondary fall in conduction velocity, independent of the level of tissue ATP. Thus, LCACs accumulate during myocardial ischemia and contribute substantially to the initiation of cell-to-cell uncoupling. Inhibition of carnitine acyltransferase I and prevention of the increase in LCACs markedly delays cellular uncoupling and development of ischemic contracture in response to ischemia. (Circ Res. 1994; 74:83-95.) Key Words * rabbit papillary muscle * conduction delay . sodium 2-(5-(4-chlorophenyl)-pentyl)-oxirane-2-carboxylate . POCA * oxfenicine * ischemic contracture contributing factor in the rapid reversible electrophysiological derangements during ischemia is the accumulation of amphipathic metabolites at or near the sarcolemma. 7 One such metabolite, long-chain acylcarnitine, increases 3.5-fold in ischemic myocardium within 2 minutes of the onset of ischemia in vivo. 8 Inhibition of accumulation of long-chain acylcarnitines markedly attenuates the incidence of ventricular tachycardia and ventricular fibrillation induced by ischemia in vivo. 9 More recently, we have demonstrated that endogenous long-chain acylcarnitines increase > 100-fold in the sarcolemmal compartment of isolated myocytes subjected to 10 minutes of hypoxia.'0 Furthermore, there was preferential accumulation of long-chain acylcarnitines in the junctional sarcolemma to levels sevenfold greater than the amount observed in the nonjunctional regions of the sarcolemma of the same hypoxic myocytes."1 Exogenous delivery of long-chain acylcarnitine to isolated myocyte cell pairs resulted in a time-dependent and reversible reduction in gap junctional conductance within 45 seconds of exposure to the amphiphile. 11 Accordingly, the purpose of the present study was to test the hypothesis that endogenous accumulation of long-chain acylcarnitines during myocardial ischemia contributes to cellular uncoupling and the associated slowing in conduction velocity. The blood-perfused papillary muscle preparation subjected to selected intervals of ischemia was used to determine (1) whether longchain acylcarnitines accumulate and are associated with cellular uncoupling during myocardial ischemia, and (2) whether prevention of the accumulation of long-chain acylcarnitines modifies cellular uncoupling and the extent of conduction delay in response to ischemia.
Materials and Methods Preparation and Perfusion of Papillary Muscles
The methods for the preparation of the isolated arterial blood-perfused rabbit papillary muscle have been described in detail previously.6'12 Briefly, rabbits weighing 2 to 3 kg were anticoagulated with heparin (200 U/kg IV) and anesthetized with pentobarbital (50 mg/kg IV). The hearts were excised, placed in cold (4°C) Tyrode's solution with [K'] of 8.5 mmol/L, and transported to a dissection tray. The atria, left ventricular free wall, and the nonperfused portion of the right ventricle were removed. The left ventricular septal surface of the tissue was attached to a wax platform that contained the ground electrode. The septal artery was cannulated and perfused with a Tyrode's solution of the following composition: insulin (1 U/L), heparin (400 U/L), albumin (M,, 67 000; 26.8 g/L), dextran (Mr, 70 000; 15 g/L), sodium palmitate (167 mg/L), Na+ (149 mmol/L), K' (4.5 mmol/L), Mg 2+ (0.49 mmol/L), Ca21 (1.8 mmol/L), Cl-(133 mmol/L), HCO3-(25 mmol/L), HP042-(0.4 mmol/L), and glucose (20 mmol/L). The total time from excision of the heart and cannulation of the septal artery before perfusion was always <4 minutes in each experiment and averaged 3.3±0.2 minutes.
Once the preparation was placed in the recording chamber, it was perfused through the native septal artery with the above Tyrode's solution containing washed bovine erythrocytes (hematocrit, 25% to 35%; 36±1°C) and surrounded by an artificial gaseous atmosphere consisting of 95% 02-5% CO2 at 36±10C (Fig 1) . Arterial perfusion with blood in the absence of superfusion largely excludes extracellular electrical shunting and maintains a physiological ratio of intracellular and extracellular spaces. Perfusion pressure was measured with a transducer (Gould, Cleveland, Ohio) and maintained between 40 and 50 mm Hg by adjustment of the perfusion flow rate (0.8 to 1 mIL * min-1 . g-') via a roller pump (Ismatec, Switzerland). This perfusion pressure is considered to be normal for small arteries in the rabbit heart (diameter at the site of cannulation, --150 jam) because comparable pressures were obtained in the microvasculature (small and medium arterioles) of cat myocardium, and "'"50% of peripheral vascular resistance is located in arteries >130 ,um in diameter. 13 The tendinous end of the papillary muscle was fixed to a force transducer (model AE802, SensoNor, Horton, Norway)
for tension measurements. The resting length of the muscle was stretched to --20% above slack length.
Measurement of Perfusate pH and of Pco2 and Po2 in the Artificial Atmosphere Surrounding the
Papillary Muscle
Perfusate. During normal perfusion, the partial pressures of 02, N2, and CO2 were controlled with a custom-built gas exchanger with Silastic membrane (Dow Corning, Midland, Mich). The pH of the perfusate was monitored continuously during the experiment by a pH glass electrode (Fisher Scientific, St Louis, Mo) fixed in the perfusion line. The Po2 was kept constant at a value >100 mmHg in each experiment during normoxic blood perfusion. The relative amounts of N2 and CO2 were adjusted to yield the required pH (7.35 to 7.45) of the perfusate. Stainless-steel or thick-wall Teflon tubing was used between the membrane gas exchanger and the recording chamber to minimize diffusional losses of gases.
Artificial atmosphere of the recording chamber. The flow of the gas mixture (95%02-5% C02) around the perfused preparation was directed through the recording chamber such that a steady convective flow of H20-saturated heated gas E4 E3 E2 El Schematic diagram of the papillary muscle and septal preparation mounted on a wax block (hatched area) containing a ground plate (thick line) and connected to a force transducer via the muscle tendon. The stippled area represents the warmed, humidified gaseous atmosphere surrounding the muscle. E1 and E3 are extracellular electrodes, E2 is a K+-sensitive electrode, and E4 is an intracellular floating microelectrode. A, Current tracing is shown, where is the subthreshold current pulse. The excitatory current pulse is shown to the right of the dotted line. B, Tracing shows extracellular voltage (E3 to El). Vst is the subthreshold membrane response, Vo is the differential bipolar electrogram recorded during spread of excitation from the tip of the muscle to the base, and t is the conduction time between electrodes E3 and E1, used for calculation of conduction velocity. C, Tracing shows transmembrane voltage as recorded by the intracellular microelectrode E4, with E3 as reference. Vm is the action potential amplitude. Note the different time scales on each side of the vertical dotted line.
surrounded the muscle. The total volume of the chamber was exchanged within 30 seconds by the continuous gas flow.
In experiments in which ischemia was induced, the atmosphere in the recording chamber was changed from a mixture of 95% 02-5% CO2 to a mixture of 95% N2-5% CO2 1 minute before cessation of coronary perfusion. The oxygen contamination of the atmosphere in the recording chamber during ischemia and hypoxia was <5 mm Hg, as measured after each experiment with a gas absorption method described previously. '4 Electrophysiological Recordings and Data Acquisition
The transmembrane action potential was recorded as the voltage difference between an intracellular floating glass microelectrode and an extracellular electrode. The extracellular voltage (V,1) during subthreshold current flow and the amplitude of the bipolar extracellular electrogram (V,) during excitation were recorded between extracellular electrodes El and E3 (Fig 1) . All extracellular and intracellular electrodes were connected to high-input impedance amplifiers. The strength of the subthreshold current pulse was measured by a current-voltage converter connected between the preparation and ground. Amplified analog signals were converted to digital at a sampling rate of 3 kHz and analyzed with LABVIEW (National Instruments, Austin, Tex) on a Macintosh lix computer (Apple Computer, Inc, Cupertino, Calif). The diameter of the papillary muscle and the interelectrode distance (Ax) were measured with a graduated reticle in the eyepiece of a binocular microscope.
The theory and application of linear cable analysis for assessment of passive cablelike electrical properties of thin cylindrical papillary muscles have been described previously in detail.612 In brief, when two different stimulation waveforms, a subthreshold and an excitatory current pulse, are applied at the tip of the papillary muscle, V,, caused by flow of the subthreshold current (I), V0, and action potential amplitude (Vm) during excitation caused by a suprathreshold current can be measured (Fig 1) . The longitudinal tissue (rt), extracellular (r0), and intracellular (ri) resistances are obtained from the following equations:
(1) q= r/ri = 1V.1/(lVmI -lV.l) (2) 
where q is the ratio of extracellular to intracellular resistances. From Equations 1 and 2, r0 and ri become
and (4) The calculation of ri and r0 requires linear cable properties. Accordingly, the following assumptions have been made: (1) Uniform continuous propagation of an impulse occurs through the muscle. (2) The cross-sectional area of the muscle remains constant. (3) Extracellular and intracellular resistive elements (resistance per unit length) are considered to be homogeneously distributed. 6 In such a case, the tissue resistance per unit length corresponds to ri and r0 in parallel. These assumptions have been verified during both normoxia and ischemia.6"2 As uncoupling progresses, propagation becomes discontinuous, the muscle becomes refractory to stimulation, action potentials cannot be evoked, and thus ri and ro cannot be determined. Additionally, with muscles of larger diameter (>1.2 mm), inexcitability during ischemia often develops before uncoupling because of greater K' accumulation, and again, action potentials cannot be evoked. However, measurement of rt is independent of propagation. Therefore, changes in rt can be obtained throughout the ischemic interval and are presented as an indicator of cell-to-cell uncoupling, as described previously. 15 Longitudinal conduction velocity (in centimeters per second) was calculated by dividing the distance between the two extracellular electrodes, Ax, by the conduction time (time between deflection and inflection on the extracellular electrogram; see Fig 1) . The data have been expressed as conduction velocity because of the uniform nature of propagation in these muscles (ie, the conduction pathway does not change). In these experiments, only cylindrical papillary muscles were used rather than clubbed or double-headed muscles to ensure that uniform propagation along the longitudinal axis of the muscle was recorded as shown previously.1215 During early ischemia before uncoupling, movement of the electrodes (ie, changing Ax) resulted in a linear conduction profile,'2 indicating that slowed conduction induced by ischemia still propagated in a uniform manner through the papillary muscle.
At selected time intervals, the papillary muscle was freezeclamped in situ within the recording chamber with artery forceps cooled to -270°C in liquid N2; tissue samples were stored at -70°C for later biochemical analysis.
Measurement of [K],
The voltage sensitive to the extracellular K' activity (aKo) was measured as the potential difference between an extracellular reference electrode and a miniature extracellular K+sensitive electrode (Fig 1) . Manufacture 
Preparation of Tissue for Measurement of Biochemical Metabolites
Each frozen papillary muscle was weighed directly into 500 ,uL cold (4°C) perchloric acid (7%) in a glass homogenizer tube and homogenized immediately at 4°C. The homogenate (100 ,uL) was placed in an Eppendorf tube and centrifuged at 8800g for 5 minutes in an Eppendorf centrifuge model 5413.
The supernatant was removed and neutralized with KOH (2.5N). The potassium perchlorate precipitate was removed by centrifugation at 8800g for 5 minutes. The supernatant was frozen at -70°C overnight before high-performance liquid chromatography (HPLC) quantification of high-energy phosphates (see below). The protein pellet from the first centrifugation was resuspended in 1 mL distilled water and used to quantify the protein content of the muscle, using a modification of the Lowry method described by Markwell et al,19 with lyophilized bovine serum albumin (Protein Standard II, Bio-Rad, Richmond, Calif) as the protein standard. The remaining 400 gL of the homogenate was added to 100 ,uL of 7% perchloric acid in an Eppendorf tube and used to quantify long-chain acylcarnitine levels in the papillary muscle (see below).
Measurement of Tissue Adenine Nucleotides
High-energy phosphates were separated and quantified using an HPLC method adapted from that described by Dubyak and Scarpa.20 Separations were performed using an HPLC system (Waters Chromatography, Milford, Mass) consisting of a model 510 HPLC pump, an injector (Rheodyne Inc, Cotati, Calif), and a model 484 tunable absorbance detector, set at a wavelength of 214 nm, interfaced to an IBM PC-AT computer using a 900 series interface and 3000 series chromatography data system software (Nelson Analytical, Cupertino, Calif). Samples (10 to 50 gL) were injected onto an HI-Pore RP-318 reverse-phase HPLC column (Bio-Rad) and eluted with an isocratic mobile phase of 0.1 mol/L ammonium phosphate, pH 5.5, at a flow rate of 0.5 mL/min. Under these conditions, all phosphometabolites of interest eluted from the column within 20 minutes. Quantification of each metabolite was determined by comparing the integrated peak area to a linear regression curve constructed from the integrated peak areas obtained from injecting 0.2 to 1.0 nmol of phosphocreatine, ATP, ADP, and AMP standards and 0.5 to 2.5 nmol of creatine standard (Sigma Chemical Co, St Louis, Mo). Phosphometabolite levels were corrected for protein content for each muscle and expressed as nanomoles per milligram protein.
Measurement of Tissue Long-Chain Acylcarnitines
Modification of a previously published method9"0 was required to measure long-chain acylcarnitines in papillary mus-ri = [VJIAxl[(1 + q)/q] cles weighing only :5 mg. Total carnitine, long-chain acylcarnitine, total acid-soluble carnitine, and free carnitine fractions in individual papillary muscles were separated on the basis of insolubility of long-chain acylcarnitine esters in 7% perchloric acid and were subsequently subjected to base-catalyzed hydrolysis of esterified carnitine. An aliquot (100 ,uL) of the homogenate was removed for assay of the total carnitine fraction. The remaining suspension was centrifuged at 8800g for 5 minutes, the supernatant was removed, and the pellet was washed once with 250 ,L of 7% perchloric acid and resuspended in 250 ,L of distilled water for assay of the long-chain acylcarnitine fraction. The supernatant and perchloric acid wash were combined, and one half of the total volume was used for assay of total acid-soluble carnitine. The remainder was used for assay of free carnitine. A 100-,uL volume of 1ON KOH was added to the total carnitine, long-chain acylcarnitine, and total acid-soluble carnitine fractions, each of which was then hydrolyzed for 90 minutes at 70°C in a water bath to obtain free carnitine. Fractions were neutralized by the addition of 500 ,L of 1 mol/L HEPES buffer (pH 8.0), and an additional 70% perchloric acid or 1ON KOH was added to adjust the pH to between 7 and 8. The potassium perchlorate precipitate remaining after neutralization was removed by centrifugation at 8800g for 5 minutes and then washed with 250 pL distilled water.
Free carnitine was measured in each fraction using a modification of the radioenzymatic method of McGarry and Foster.21 Assays were performed in disposable glass culture tubes. The reaction mixture contained, in a volume of 1 mL, 120 ,umol HEPES buffer (pH 7.4), 1.25 ,umol EDTA, 2 ,mol N-ethylmaleimide, 1 nmol (0.12 ,Ci) [3H]acetyl coenzyme A (New England Nuclear, Boston, Mass), and standards or samples to be analyzed containing 2 to 100 pmol free carnitine. The reaction was initiated by the addition of 50 pL of a solution prepared by diluting 200 ,uL of carnitine acetyltransferase (Sigma) and 150 pL of 0.83 mol/L HEPES buffer (pH 7.4) to a volume of 2 mL with distilled water. Samples were incubated at room temperature for 60 minutes. After incubation, 900 ,uL of the reaction mixture was transferred to a serum separator tube (Baxter Healthcare Corp, McGaw Park, Ill) with a 5-,um filter that contained 700 to 800 mg acid-washed Dowex AG 1-X8 anion exchange resin (Bio-Rad) for removal of unreacted [3H]acetyl coenzyme A from the reaction mixture. The serum separator tube was placed inside a 13 x 100-mm glass culture tube to form an airtight seal, thereby allowing the reaction mixture to filter through the anion exchange resin when the serum separator tube was withdrawn partially. The resin bed was washed with an additional 300 ,uL distilled water, and the serum separator tube was withdrawn completely. A 900-pL volume of the filtrate containing the [3H]acetylcarnitine reaction product was added to 10 mL of 3a-70 scintillation cocktail (RPI, Mount Prospect, Ill), and radioactivity in the samples was counted using a Beckmann model LS-3801 liquid scintillation counter. A standard curve was constructed from the least-squares linear regression analysis of the carnitine standards and used to determine carnitine content in the samples, expressed in picomoles per milligram protein. Long-chain acylcarnitine values were compared with total carnitine, short-chain acylcarnitine, and free carnitine values for validation and quality control of the assay. The latter values were comparable to those reported previously. 9 Only long-chain acylcarnitine values are presented here.
Experimental Protocol
The papillary muscle preparations were stimulated by application of a constant current pulse, through a silver wire, from apex to base of the muscle at a basic cycle length of 500 milliseconds. In each experiment, control measurements were obtained after the preparation had stabilized in the chamber for a minimum of 30 minutes. After 15 minutes of control recording, each muscle was subjected to either 15 to 20 minutes of continued normoxic control perfusion or 2 to 40 minutes of zero-flow ischemia. Zero-flow ischemia was produced by the abrupt and complete cessation of arterial perfusion. In two experiments, muscles were reperfused for 20 minutes after an ischemic interval of 20 minutes. Papillary muscles were freeze-clamped with hemostats cooled in liquid nitrogen 2, 5, 10, 15, 20, 25, or 40 minutes after the onset of ischemia or after 20 minutes of ischemia plus 20 minutes of reperfusion and stored at -70°C for subsequent biochemical analyses as described above. For determination of the influence of inhibition of carnitine acyltransferase I, preparations were perfused with 10 jl.mol/L sodium 2-(5-(4-chlorophenyl)pentyl)-oxirane-2-carboxylate (POCA, a generous gift from Hoffmann-La Roche, Nutley, NJ) or 100 .rmol/L oxfenicine (Sigma) 20 to 30 minutes (preischemic control period) after the normal 30-minute stabilization period before no-flow ischemia was induced for 20 or 40 minutes. Only a single ischemic interval was induced in each preparation. 
Statistical Analysis

Results
Electrophysiological and Biochemical Alterations Observed During No-Flow Ischemia
Rabbit papillary muscles perfused with Tyrode's solution containing washed erythrocytes and physiological concentrations of free fatty acid were subjected to no-flow ischemia for 15 minutes and exhibited electrophysiological alterations (Table) virtually identical to those described previously in the absence of exogenously added fatty acid substrate.6,22 The time course of cellular uncoupling, reflected by the abrupt increase in rt, is shown in Fig 2. For this representation, the muscles were divided into two groups: those with diameters .1.05 mm (n=8) and those with diameters >1.05 mm (n= 10). These groups contained muscles from which electrophysiological data alone were obtained in addition to those muscles for which biochemical as well as electrophysiological data are reported. To compare the time course of uncoupling under various experimental conditions, we have set a relative time during cellular uncoupling at which rt increased to 50% above control values, ie, 150%, to time zero.22 This is an arbitrary value used as a reference point for comparing the progression of uncoupling in muscles subjected to various interventions. In the present study, uncoupling was delayed by 5 minutes in muscles with larger diameters. Uncoupling occurred at 13 minutes in muscles with diameters <1.05 mm (0.91+0.04 mm) and at 18 minutes in muscles with diameters >1.05 mm (1.24±0.04 mm).
Tissue long-chain acylcarnitine levels were assayed in the same muscles from which the electrophysiological measurements had been obtained. Papillary muscles were freeze-clamped after 2, 5, 10, 15, or 20 minutes of no-flow ischemia. Papillary muscle weights ranged from 1.4 to 9.8 mg wet weight (mean, 5.2±0.5 mg; n=42). Measurement of biochemical indexes in these small muscles required modification of existing assays for measurement of long-chain acylcarnitines to increase APA indicates action potential amplitude (basic cycle length, 500 milliseconds); APD80, action potential duration at 80% repolarization; 0, conduction velocity; rt, longitudinal tissue resistance; and ri, intracellular resistance. Values are mean±SEM (n=18; mean diameter, 1.09±0.05 mm). the sensitivity to permit accurate detection in as little as 1 mg of tissue. Only those muscles weighing 3 mg or more were large enough for measurement of both long-chain acylcarnitines and adenine nucleotides. The time course of increase in tissue long-chain acylcarnitine content is summarized in Fig 3. After cessation of blood flow to the muscles, the tissue content of long-chain acylcarnitines rose rapidly within 5 minutes from a control value of 126+5 (n=10) to 170±19 (n=5) pmol/mg protein. Long-chain acylcarnitines increased further as the ischemic interval was prolonged and reached statistically significant levels of 293+±57 pmol/mg protein by 10 minutes (P<.01, n=4) and 344±24 pmol/mg protein by 15 minutes (P<.01, n=7).
Tissue long-chain acylcarnitine levels in muscles frozen after 20 minutes of ischemia at the time of cellular uncoupling were elevated over threefold to 397±113 pmol/mg protein (P<.01, n=4).
Two muscles were reperfused for 20 minutes after 20 minutes of zero-flow ischemia to assess the extent of reversibility of tissue long-chain acylcarnitine accumulation and the associated electrophysiological derangements. Long-chain acylcarnitine content (116 pmol/mg 300 protein, n=2) was nearly identical to control preischemic values. Conduction velocity declined from 54 to 16 cm/s after 20 minutes of ischemia (n=2; also compare with the Table) and returned to 60 cm/s after 20 minutes of reperfusion. The r, increased from 100% to 158% after 20 minutes of ischemia (n=2; see the Table) and returned to within 88% of control values after reperfusion.
The extent of accumulation of long-chain acylcarnitines during ischemia was dependent on fiber diameter. That is, tissue long-chain acylcarnitine levels after 15 minutes of no-flow ischemia were greater in smallerdiameter muscles (r=.90, Fig 4) . The relation between fiber diameter and the increase in long-chain acylcarnitine content was not a measurement artifact, because there was no relation between long-chain acylcarnitine content and fiber diameter under control normoxic conditions (r=. 36) .
Previous studies in which ischemia was induced in this blood-perfused papillary muscle preparation were performed in the absence of exogenous fatty acid in the perfusate.612,4,22,23 The decision to add physiological concentrations of palmitate to the perfusate in the present study was based on the fact that free fatty acids exist in serum in equilibrium with fatty acids bound to albumin. Although we have demonstrated a ninefold increase in long-chain acylcarnitines induced by hypoxia in isolated myocytes in the absence of exogenous fatty acids,10'11 Liedtke et a124 demonstrated that long-chain acylcarnitine production was enhanced in response to ischemia when circulating free fatty acids were elevated. Therefore, in a control series of experiments, the levels of long-chain acylcarnitines were measured under normal baseline conditions and after ischemia in muscles in which fatty acids were excluded from the perfusate. Control muscles harvested after normoxic perfusion exhibited long-chain acylcarnitine levels of 85 + 4 pmol/mg protein (n=9). Muscles harvested after 25 minutes of zero-flow ischemia exhibited a significant (P<.001) 2.5-fold increase in long-chain acylcarnitines to 216±40 pmol/mg protein (n=7). Perfusion of muscles with palmitate-free blood did not alter any of the electrophysiological responses to ischemia. Muscles uncoupled with a time course nearly identical to that ischemia as a function of muscle diameter. Muscles were divided into two groups: those with diameters <1.05 mm (-, n=8) and those with diameters >1.05 mm (o, n=10). Longitudinal tissue resistance (rt) is expressed as a percentage of control (100%). observed in the pres the seven muscles s 0.95 to 1.47 mm, wit there was an inverse time of onset of uncc content. Although b acylcarnitine levels l the absence of palm] of fatty acid substrm chain acylcarnitines ble to that observed Adenine nucleoti muscles subjected to in the presence of from a control value (P<.05) after 5 mini for the remainder c ( Fig 5) . The modest ischemia was not st either 10 or 20 mi muscles perfused without palmitate decreased from 34±1 to 10±1 nmol/mg protein after 25 minutes of ischemia, analogous to that seen in the presence of palmitate in the perfusate. A further reduction in tissue ATP to 3±1 nmol/mg protein was observed after 40 minutes of ischemia. Influence of Inhibition of Carnitine Acyltransferase I by POCA or Oxfenicine on Long-Chain Acylcarnitine Accumulation and Electrophysiological Alterations During Ischemia Influence of POCA pretreatment during subsequent ischemic period. POCA has been shown to prevent accumulation of long-chain acylcarnitines in ischemic tissue in vivo9 and in hypoxic myocytes in vitro. 10, 25, 26 In the present study, POCA completely prevented the 12 5 10 15 20 increase in tissue content of long-chain acylcarnitine in TIME OF ISCHEMIA (min) arterially perfused rabbit papillary muscles subjected to no-flow ischemia (Fig 6) . Ning tissue long-chain acylcarnitine con-nofo shma(i ) iving tissue long-cain acylcarnier cofl POCA (n=8) markedly delayed cellular uncoupling, vidual papillary muscles under control after 2 minutes (n=6), 5 minutes (n=5), as indicated by the lack of increase in both r, ( Fig 7A) ninutes (n=7), and 20 minutes (n=4) of and ri (not shown) during the first 15 minutes of no-flow '<.01 vs control.
ischemia. Additional muscles pretreated with POCA (n=6) were subjected to 40 minutes of ischemia to ,ence of palmitate. The diameters of determine at what time uncoupling would occur and to subjected to ischemia ranged from determine whether cell-to-cell uncoupling could be dish a mean of 1.16±0.07 mm. Again, sociated from the onset of ischemic contracture. A relation between fiber diameter or marked difference in the r, curves of the untreated )upling and long-chain acylcarnitine versus treated groups was observed ( Fig 7A) . Cell-tooth control and ischemic long-chain cell uncoupling was delayed by -8 minutes in the were lower in muscles perfused in muscles pretreated with POCA ( Fig 7A) . In addition, itate (because of the reduced levels the rate of uncoupling was considerably slower than that ate), the relative increase in long-in untreated muscles. Based on an ro to ri ratio of -1 induced by ischemia was compara-and a relatively modest change in r0 during ischemia, in the presence of palmitate. complete uncoupling (r, approaching oo) would occur in ides were measured in the same a theoretical cable at r,=230%.22 In untreated muscles, 2 to 40 minutes of no-flow ischemia r, increased rapidly from the onset of uncoupling at 15 palmitate. ATP levels fell rapidly minutes to >200% of the control value within 5 minof 34±2 to 14±2 nmol/mg protein utes. In contrast, in muscles treated with POCA, r, utes of ischemia and remained low eventually increased to the same level but at a far slower )f the 20-minute ischemic interval rate over a subsequent 15-minute interval. Since the change in ATP after 15 minutes of time to uncoupling was dependent on fiber diameter atistically different from values at (Fig 4) , the diameters of the muscles with and without nutes of ischemia. ATP levels in POCA had to be taken into consideration. The mean diameter of untreated muscles subjected to ischemia (1.09+0.05 mm, n=18) was not significantly different from the mean diameter of muscles pretreated with POCA (1.14±0.03 mm, n=14). Both groups contained muscles with smaller and larger diameters. This is in contrast to the two groups represented in Fig 4, which contained smaller diameter versus larger diameter muscles exclusively. Therefore, although the mean diameters of the untreated muscles (1.09 mm) and those treated with POCA (1.14 mm) were similar to the larger diameter (>1.05 mm) muscle group (1.24 mm), the uncoupling curves of the former groups exhibit earlier increases in r, and ri because the smaller diameter muscles in these two groups were more sensitive to uncoupling. It has been shown that cell-to-cell uncoupling observed during ischemia occurs concomitantly with a secondary increase in extracellular K+27 and development of ischemic contracture. 22 Therefore, the effect of T T CONTROL POCA on ischemia-induced increases in extracellular K' and resting tension was investigated. Interestingly, the onset of contracture was delayed by an additional 10 to 15 minutes in muscles pretreated with POCA ( Fig   7B) . In contrast to the concomitant increase in r, and resting tension observed at :15 minutes of ischemia in untreated muscles, the increase in r, preceded the increase in resting tension (ie, ischemic contracture) by z5 to 7 minutes in muscles treated with POCA. In the present experiments, we did not isolate the mechanical twitch of the papillary muscle from the contractile activity of the interventricular septum, as described previously.22 Therefore, the latter may have confounded an earlier increase in resting tension in the papillary muscle. Nevertheless, once initiated, the increase in resting tension progressed with a similar time course in both groups.
POCA did not significantly influence the early increase in extracellular K' occurring during the first 10 minutes of ischemia ( Fig 8A) . In untreated muscles, the initial rise in extracellular K' and the subsequent plateau were followed by a secondary rise in K', which was coincident with the onset of cellular uncoupling (at r,= 150% of control) and the onset of ischemic contracture, as previously described.22 However, in the muscles treated with POCA, extracellular K' reached the initial plateau after 10 minutes and then even decreased slightly thereafter (20 minutes of ischemia, Fig 8A) . POCA pretreatment delayed the secondary increase in extracellular K' by -15 minutes ( Fig 8A) .
Longitudinal conduction velocity decreased markedly in untreated ischemic muscles before the onset of cellular uncoupling and exhibited a secondary rapid decline after 15 minutes of zero-flow ischemia. Although the initial decline in conduction velocity was not affected by pretreatment with POCA, the secondary decline was markedly attenuated (Fig 8B) .
The influence of POCA on electrophysiological indexes and mechanical function was not due to preservation of tissue ATP content. As shown in Fig 9, there were no significant differences in tissue ATP levels after 20 minutes of ischemia in muscles treated with POCA (13.4+2.5 nmol/mg protein, n=6) compared with untreated muscles (13.8±0.9 nmol/mg protein, n=4), at which time there were marked distinctions between untreated and treated muscles with respect to rt, resting tension, extracellular K' accumulation, and conduction velocity (Figs 7 and 8 ). POCA did not alter the marked reduction in ATP observed in papillary muscles subjected to 40 minutes of no-flow ischemia (Fig 9) .
Influence of oxfenicine pretreatment during subsequent ischemic period. The final series of muscles was pretreated with oxfenicine, an inhibitor of carnitine acyltransferase I (n=4), before the onset of ischemia of 40-minute duration. These experiments were designed to exclude a nonspecific effect of POCA to delay uncoupling, potentially by stabilizing cell membranes as a result of its charge distribution. Although both POCA9,10,25,26,28-30 and oxfenicine31-33 inhibit carnitine acyltransferase I in vitro and in vivo, they are structurally dissimilar and likely inhibit the enzyme via different mechanisms based on differences in the mechanism and sites of action of tetradecylglycidic acid (the prototype compound for POCA) and 4-hydroxyphenylglyoxylate (the active metabolite of oxfenicine) compared with other product inhibitors such as acyl coenzyme A.3334
Oxfenicine also prevented the increase in long-chain acylcarnitines in papillary muscles exposed to 40 minutes of ischemia (Fig 6) . The onset of cell-to-cell uncoupling (Fig 7A) , the onset of ischemic contracture (Fig 7B) , the secondary increase in extracellular K' (Fig 8A) , and the secondary decline in conduction velocity ( Fig 8B) were all delayed by pretreatment with oxfenicine. Even in the presence of POCA or oxfenicine, however, the mus-CONTROL ** ** cles became inexcitable 21 to 23 minutes after the onset of ischemia. Thus, conduction velocity could not be determined beyond 23 minutes of ischemia. Finally, oxfenicine did not alter the reduction in ATP observed in muscles subjected to 40 minutes of no-flow ischemia (Fig 9) . [POCA, n=4] ). These data indicate that the effect of POCA to delay cell-to-cell uncoupling, increases in extracellular K+, and decreases in conduction velocity during ischemia was not due to a reduction in actively developed tension before the onset of ischemia.
Discussion
The results of the present study demonstrate that long-chain acylcarnitines increase >300% over control values during myocardial ischemia and contribute to the early increase in resting tension and cell-to-cell uncoupling. Tissue accumulation of long-chain acylcarnitines and electrophysiological derangements were reversible with reperfusion after 20 minutes of zero-flow ischemia. Most important, inhibition of the accumulation of longchain acylcarnitines in ischemic tissue markedly delayed cell-to-cell uncoupling, supporting our previous findings of a marked decrease in junctional conductance in isolated myocyte cell pairs by exogenous long-chain acylcarnitines."1
The electrophysiological alterations resulting from zero-flow ischemia in this blood-perfused preparation in the absence of exogenously added fatty acid have been described in detail previously6"12,1722 and are confirmed by the present findings in the presence of physiological concentrations of fatty acid substrate. Typically, the initial phase of ischemia after cessation of blood flow is characterized by rapid accumulation of extracellular K' and a decrease in electrical excitability without appreciable changes in electrical cell-to-cell coupling. Elevations in extracellular K' and a reduction in tissue excitability contribute to an early decline in conduction velocity. Modest increases in r0 on the order of 20% occurred during the first 10 minutes of ischemia (not shown), at a time when extracellular K' increased -2.5-fold. The increase in ro is likely due to a fall in intravascular volume and to shrinkage of the extracellular space. After 10 to 15 minutes of ischemia, the onset of cell-to-cell uncoupling occurs, a process that is relatively abrupt in onset and complete within 5 to 10 additional minutes of ischemia.6'22 During uncoupling, extracellular K' began its secondary rise, ri increased sharply, and ro did not change significantly. Therefore, the influence of r0 on conduction velocity slowing was relatively small compared with the loss of excitability and junctional coupling. In addition to monitoring the electrophysiological alterations leading to uncoupling during ischemia, we measured tissue long-chain acylcarnitines and adenine nucleotides in response to ischemia in individual papillary muscles from which the electrophysiological recordings were made. Long-chain acyl-carnitines increased after 5 minutes of ischemia in the blood-perfused papillary muscle preparation and continued to increase as the ischemic interval was extended to 20 minutes. This time course is similar to that observed during hypoxia in vitro102526 but is substantially slower than the increase during ischemia in vivo (ie, 3.5-fold after 2 minutes8). We currently have not determined the precise factor(s) present or event(s) occurring in vivo that may be responsible for the accelerated increase of long-chain acylcarnitines observed under those conditions. Long-chain acylcarnitine levels remained elevated after 40 minutes of ischemia but were not significantly greater than after 20 minutes of ischemia, likely because of the limitation by (1) feedback inhibition of carnitine acyltransferase I, (2) reduced uptake of free fatty acids during ischemia, and (3) hydrolysis of long-chain acylcarnitines by acylcarnitine hydrolase. Accumulation of long-chain acylcarnitines occurred more rapidly and to an increased level in smallerdiameter muscles. In addition, uncoupling occurred more rapidly in smaller-diameter muscles. Muscle diameter has previously been shown to influence two important parameters during ischemia: the extent of acidification and the accumulation of extracellular K'. The dependence of these two parameters on muscle diameter originates from the fact that C02, a diffusible gas, is formed from HCO3during ischemia by metabolic acidification. Smaller-diameter muscles, through which CO2 may diffuse more readily, exhibit relatively lower Pco2 and therefore higher pH. and pHi values in response to ischemia (G.-X. Yan and A.G. Kleber, unpublished data), as opposed to larger-diameter muscles, in which CO2 would accumulate, creating a CO2 gradient from the core to the surface of the muscle. Furthermore, extracellular K' accumulation induced by ischemia occurs to a lesser extent in smaller-diameter muscles. 23 Indeed, the rise in extracellular K' and associated changes in membrane potential occurring in response to ischemia are likely to be related directly to a lack of CO2 diffusion and resulting intracellular acidification. 23 The activity of carnitine acyltransferase I is greater at a more alkaline pH. 35 This may account for the greater accumulation of long-chain acylcarnitines in smaller-diameter ischemic muscles. Data obtained by Cascio demonstrate that electrophysiological alterations occur more rapidly and tissue damage is greater in smaller diameter muscles after reperfusion following ischemia (W.E. Cascio, unpublished data). The fact that uncoupling occurred more rapidly in smaller-diameter muscles associated with a larger increase in long-chain acylcarnitines further supports the concept that accumulation of this amphiphile contributes to early cell-tocell uncoupling during ischemia. That inhibition of long-chain acylcarnitine accumulation delayed uncoupling also supports this conclusion.
The present experiments demonstrate that inhibition of long-chain acylcarnitine accumulation during ischemia delays both the onset and rate of electrical cellto-cell uncoupling. Several mechanisms have been invoked to account for cell-to-cell uncoupling observed during myocardial ischemia, including intracellular and extracellular acidification,'4 intracellular Ca'4 overload,36'37 ATP depletion,3839 or sarcolemmal accumula-tion of long-chain acylcarnitines.1" However, we have obtained evidence supporting the involvement of longchain acylcarnitines in the initiation of electrical cell-tocell uncoupling by inhibiting gap junctional conductance via direct interaction with gap junctional proteins. Longchain acylcarnitines are selectively and reversibly incorporated into cardiac sarcolemma after brief periods of hypoxia,'0,25 and they accumulate preferentially in the junctional regions of the sarcolemma of isolated cardiac myocytes."1 The tissue concentrations of long-chain acylcarnitines obtained in the present study after 20 minutes of ischemia are comparable to values obtained in isolated myocytes subjected to hypoxia.10'25 Thus, the membrane concentration of long-chain acylcarnitines incorporated into ischemic papillary muscle sarcolemma is likely to be comparable to that observed in hypoxic myocyte sarcolemma (1 to 4 mol%10'11"25). Furthermore, long-chain acylcarnitines markedly and reversibly inhibit gap junctional conductance, independent of the level of intracellular Ca 2+, assessed using double whole-cell voltage-clamp procedures with and without EGTA.1" These data support previous reports demonstrating that increases in cellular Ca2' alone are unlikely to cause uncoupling.4041 However, in addition to the direct effect of long-chain acylcarnitines on gap junctional conductance," there is evidence that longchain acylcarnitines can increase intracellular Ca2' and may thereby modulate cell-to-cell uncoupling. Despite the fact that long-chain acylcarnitine inhibits the L-type Ca 2 current,42 this amphiphile has been shown, albeit indirectly, to increase intracellular Ca +.42-44 More recently, we have demonstrated by direct measurements of indo 1 fluorescence that long-chain acylcarnitine increases intracellular Ca 2+ in isolated adult ventricular myocytes. 45 Thus, long-chain acylcarnitine-mediated initiation of cell-to-cell uncoupling is likely due to effects both on gap junctional conductance per se and secondary to increases in intracellular Ca2 .
The effect of carnitine acyltransferase I inhibitors (ie, the delay of uncoupling) should be contrasted with that of Ca2+ channel blockers, which have also been shown to delay the onset and decrease the rate of electrical uncoupling observed during ischemia.22 Ca21 channel blockers decreased the mechanical activity of the tissue before ischemia, resulting in reduced energy demands during the subsequent ischemic period. In contrast, POCA does not affect active tension development or other mechanical or electrophysiological properties of the myocardium before ischemia (References 9, 28, and 46 and the present study) and is thus unlikely to alter Ca2' homeostasis before the onset of ischemia. That uncoupling eventually occurred despite the administration of POCA underscores the multifactorial nature of the uncoupling process. Clearly, other factors such as intracellular acidosis, depletion of ATP, influx of Ca'+, and eventual cell death each influence uncoupling as well.
POCA pretreatment did not attenuate the early decline in conduction velocity, which is likely due to elevations in extracellular K+ and a reduction in tissue excitability as discussed above. However, POCA markedly delayed the secondary decrease in conduction velocity normally observed in response to ischemia. The secondary slowing in conduction velocity is likely due to a reduction in excitability (secondary extracellular K' rise), a decline in propagation due to an increase in resistance to local current flow ahead of the propagating wave front, and a reduction in membrane potential with depression of the rapid inward Na+ current.25 Longchain acylcarnitines have been shown to decrease the rapid inward Na+ current.47 Thus, the delay in the slowing of the conduction velocity by POCA in the secondary phase of ischemia is likely caused by not only the delay of the secondary rise in extracellular K' but also the attenuation of ischemia-induced depression of the rapid inward Na+ current secondary to membrane depolarization and delay of inhibition of gap junctional conductance. However, we can reach no conclusions as to the relative importance of depression of the rapid inward Na+ current versus the inhibition of gap junctional conductance induced by long-chain acylcarnitines on the basis of the present data. Slowing in conduction velocity is a key factor in the initiation of reentrant circuits, which we34 and others48 have shown contribute substantially to arrhythmogenesis in ischemic myocardium in vivo. Therefore, although loss of excitability may be responsible for early changes in conduction velocity, changes in excitability as well as a reduction in junctional coupling, both induced by long-chain acylcarnitine accumulation during ischemia, play a major role in subsequently establishing the substrate for the genesis of reentrant arrhythmias in vivo.
Inhibition of carnitine acyltransferase I by POCA may result in other metabolic alterations within the tissue, including decreased extraction of free fatty acids,49 decreased oxidation of fatty acids resulting in decreased myocardial°2 consumption, and enhanced glucose utilization.28,2950,51 Stimulation of glucose oxidation independent of inhibition of long-chain acylcarnitine accumulation is one mechanism by which some investigators explain the beneficial effect of inhibition of carnitine acyltransferase I by etomoxir during ischemia. 52 However, treatment with POCA does not result in attenuation of the depletion of high-energy phosphates during ischemia. ATP levels in muscles in which uncoupling had not yet occurred in the presence of carnitine acyltransferase I inhibition were extremely low and nearly identical to those measured in untreated muscles at the time of marked cellular uncoupling. Therefore, POCA did not exert its beneficial effects by preserving tissue ATP levels, in agreement with findings of others that POCA does not significantly alter ATP or tissue lactate in response to ischemia. 46 Nearly identical results on cell-to-cell coupling were seen also with a structurally different inhibitor of carnitine acyltransferase I, oxfenicine, suggesting that inhibition of longchain acylcarnitine accumulation was the significant ameliorative metabolic effect produced by POCA in blood-perfused papillary muscle preparations.
In conclusion, the results of the present study demonstrate that accumulation of long-chain acylcarnitines in response to ischemia contributes to initiation of electrical cell-to-cell uncoupling and associated disturbances of impulse propagation, which may lead to lethal arrhythmias in ischemic myocardium in vivo. The specific cellular mechanisms whereby long-chain acylcarnitines exert their deleterious effects are currently under investigation. Our data suggest that therapeutic interventions aimed at inhibiting long-chain acylcarnitine accumulation may ameliorate functional derangements induced during the early stages of myocardial ischemia.
